EAU Guidelines on Penile Cancer: 2014 Update

Oliver W. Hakenberg(University of Rostock), Nick Watkin(St George’s University Hospitals NHS Foundation Trust), Éva Compérat(Vienna General Hospital), Chris Protzel(Helios Kliniken), Suks Minhas(Charing Cross Hospital), Andrea Necchi(Vita-Salute San Raffaele University)
European Urology
November 1, 2014
10.1016/j.eururo.2014.10.017
Cited by 594

Related Papers

Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial
|The Lancet|2016|3.7k
Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma
|New England Journal of Medicine|2017|3.4k
Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial
|The Lancet|2016|2.2k
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 Guidelines
|European Urology|2023|618
European Association of Urology Guidelines on Male Sexual and Reproductive Health: 2021 Update on Male Infertility
|European Urology|2021|612